Qunjun Gao
Shenzhen, 518000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Retraction notice to "High expression of enhancer RNA MARC1 or its activation by DHT is associated with the malignant behavior in bladder cancer" [Exp. Cell Res. Volume 370, Issue 2, 15 September 2018, Pages 303-311].
Journal: Experimental cell research
Published: August 31, 2024
Multiplexed promoterless gene expression with CRISPReader.
Journal: Genome biology
Published: January 03, 2019
Lentivirus-mediated shRNA targeting MUTYH inhibits malignant phenotypes of bladder cancer SW780 cells.
Journal: OncoTargets and therapy
Published: October 03, 2018
OIP5 Promotes Growth, Metastasis and Chemoresistance to Cisplatin in Bladder Cancer Cells.
Journal: Journal of Cancer
Published: May 21, 2018
Enhancer RNA - P2RY2e induced by estrogen promotes malignant behaviors of bladder cancer.
Journal: International journal of biological sciences
Published: May 08, 2018
High expression of enhancer RNA MARC1 or its activation by DHT is associated with the malignant behavior in bladder cancer.
Journal: Experimental cell research
Published: April 24, 2018
Long non-coding RNA CRNDE in cancer prognosis: Review and meta-analysis.
Journal: Clinica chimica acta; international journal of clinical chemistry
Published: March 28, 2018
Current Advances on the Important Roles of Enhancer RNAs in Gene Regulation and Cancer.
Journal: BioMed research international
Published: January 04, 2018
Synthetic artificial "long non-coding RNAs" targeting oncogenic microRNAs and transcriptional factors inhibit malignant phenotypes of bladder cancer cells.
Journal: Cancer letters
Published: December 20, 2017
Last Updated: 09/26/2026